Digital Health
Innovation Platform
Bringing experts together to stimulate ideas at an early stage: We promote digitalization in healthcare.
Due to the current situation, d.hip is closed to the public.
However, you can contact us at any time.
d.hip – the innovation alliance between industrial, clinical and technological research:
About d.hip:
The increasing digitalization of medicine is changing the requirements of modern healthcare and at the same time offers various new opportunities for a more efficient healthcare system. Tackling these requirements and opportunities and helping to shape the digital transformation ask for very unique conditions and infrastructure – the regional proximity of clinical care at the highest healthcare level at the Erlangen University Hospital, the renowned research and science at Friedrich-Alexander University Erlangen-Nuremberg, the internationally recognized Cluster for medical technology “Medical Valley EMN” and Siemens Healthineers, as the leading company in the medical technology industry.
With the establishment of the Digital Health Innovation Platform (d.hip) as a cooperative alliance of industry, university medicine and research, their partners have therefore jointly set themselves the goal to actively advance the digitalization of medicine and healthcare. d.hip is intended to serve as a platform for the transdisciplinary development of new strategies, products and solutions. At the same time, it should provide the participants with suitable framework conditions for practical research and development at a higher speed in the innovation cycle.
The Digital Health Innovation Platform (d.hip) is a cooperation platform of industry, university medicine and research that creates joint synergies to develop and steer the decisive, day-by-day advancement steps of digital health.
clinical data
administration
Our mission is to enable the handling and use of clinical data for research projects in collaboration with industry.
ethical
responsability
data
protection
In this context, we give top priority to ethical responsibility and the protection of sensitive private data.
We guarantee to abide by the guiding principle that clinical data can only be used in a responsible context, in which fundamental ethical considerations take a leading role and and patients' rights are protected to an absolute maximum.
Our region, the so-called Medical Valley, is a globally unique composition of university medicine, internationally renowned companies and university and non-university research institutions, which together have enormous potential to imminently influence new diagnostics and therapies.
The four founding partners of d.hip are
- Friedrich-Alexander University Erlangen-Nuremberg,
- Erlangen University Hospital,
- Siemens Healthineers and
- the internationally recognized Cluster for medical technology “Medical Valley EMN”
Each of our partners brings their respective different expertise to the table to jointly promote research for digitization in healthcare.
In addition to the content-driven projects, we regularly organize events in our premises, the d.hip space, to promote networking and inform our partners in the field of digital health.
Together with FAU, d.hip actively supports research for digitalization of healthcare by funding four new endowed professorships and 20 PhD positions through the d.hip Digital Health Campus, which can additionally benefit from the d.hip infrastructure.
The d.hip Data Center is located directly at the University Hospital Erlangen. It supports our partners and researchers in making clinical data available through modern, robust and properly structured processes, taking into consideration ethical aspects and key requirements to comply with data protection. Using state-of-the-art computer and server capacities, the Data Center can annotate and process data that it receives from the University Hospital's Data Integration Center (DIZ) in anonymized or pseudonymized form.
The flagship of d.hip is the Digital Health Twin, which enables prediction of disease progression and risk analysis of individual patients by using and processing clinical data. The initial focus of this research is framed around two clinical application areas, namely breast health and rheumatic diseases.
Please find more information about each element on the page "about".
The development of the human digital twin is the core of d.hip. Efforts are initially concentrated on two areas.
On one hand, a complex model applicable to rheumatic diseases will be developed, the so-called Digital Rheumatic Twin (DRT).
The second field of application that d.hip is focusing on in particular is the development of a Digital Breast Twin (DBT).
The first step is to integrate preventive measures into the Digital Twin.
The Digital Health Twin will be able to make recommendations for a healthy lifestyle personalized for the respective person, to carry out an individual risk analysis or to adapt prevention intervals accordingly to personal health.
In addition to prevention, the Digital Health Twin should also be able to make predictions in case of illness.
For example, it can evaluate different therapy methods and thus help physicians decide which method has the best chance of success.
Another goal is to predict the progression of symptoms.
Lastly, follow-up appointments can be personalized e.g. in terms of intensity and intervals.
Digital Health Innovation Platform
Bringing experts together to stimulate ideas at an early stage: We promote digitalization in healthcare.
The Digital Health Innovation Platform (d.hip) is a cooperation platform of industry, university medicine and research that creates joint synergies to develop and steer the decisive, day-by-day advancement steps of digital health.
clinical data
administration
Our mission is to enable the handling and use of clinical data for research projects in collaboration with industry.
ethical
responsability
data
protection
In this context, we give top priority to ethical responsibility and the protection of sensitive private data.
We guarantee to abide by the guiding principle that clinical data can only be used in a responsible context, in which fundamental ethical considerations take a leading role and and patients' rights are protected to an absolute maximum.
Our region, the so-called Medical Valley, is a globally unique composition of university medicine, internationally renowned companies and university and non-university research institutions, which together have enormous potential to imminently influence new diagnostics and therapies.
The four founding partners of d.hip are
- Friedrich-Alexander University Erlangen-Nuremberg,
- Erlangen University Hospital,
- Siemens Healthineers and
- the internationally recognized Cluster for medical technology “Medical Valley EMN”
Each of our partners brings their respective different expertise to the table to jointly promote research for digitization in healthcare.
In addition to the content-driven projects, we regularly organize events in our premises, the d.hip space, to promote networking and inform our partners in the field of digital health.
Together with FAU, d.hip actively supports research for digitalization of healthcare by funding four new endowed professorships and 20 PhD positions through the d.hip Digital Health Campus, which can additionally benefit from the d.hip infrastructure.
The d.hip Data Center is located directly at the University Hospital Erlangen. It supports our partners and researchers in making clinical data available through modern, robust and properly structured processes, taking into consideration ethical aspects and key requirements to comply with data protection. Using state-of-the-art computer and server capacities, the Data Center can annotate and process data that it receives from the University Hospital's Data Integration Center (DIZ) in anonymized or pseudonymized form.
The flagship of d.hip is the Digital Health Twin, which enables prediction of disease progression and risk analysis of individual patients by using and processing clinical data. The initial focus of this research is framed around two clinical application areas, namely breast health and rheumatic diseases.
Please find more information about each element on the page "about".
The development of the human digital twin is the core of d.hip. Efforts are initially concentrated on two areas.
On one hand, a complex model applicable to rheumatic diseases will be developed, the so-called Digital Rheumatic Twin (DRT).
The second field of application that d.hip is focusing on in particular is the development of a Digital Breast Twin (DBT).
The first step is to integrate preventive measures into the Digital Twin.
The Digital Health Twin will be able to make recommendations for a healthy lifestyle personalized for the respective person, to carry out an individual risk analysis or to adapt prevention intervals accordingly to personal health.
In addition to prevention, the Digital Health Twin should also be able to make predictions in case of illness.
For example, it can evaluate different therapy methods and thus help physicians decide which method has the best chance of success.
Another goal is to predict the progression of symptoms.
Lastly, follow-up appointments can be personalized e.g. in terms of intensity and intervals.
Digital Health Innovation Platform
Bringing experts together to stimulate ideas at an early stage: We promote digitalization in healthcare.